Your browser doesn't support javascript.
loading
Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification.
Hird, Amanda E; Chavarriaga, Julián; Lalani, Aly-Khan A; Wallis, Christopher J D.
Affiliation
  • Hird AE; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada.
  • Chavarriaga J; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada.
  • Lalani AA; Division of Medical Oncology and Hematology, Juravinski Cancer Center, McMaster University, Hamilton, Canada.
  • Wallis CJD; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada. Electronic address: wallis.cjd@gmail.com.
Eur Urol ; 84(4): 379-380, 2023 10.
Article in En | MEDLINE | ID: mdl-37455176
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Canada Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Canada Country of publication: Switzerland